Why Farbe Firma is the Top Manufacturer of Phenobarbital Injection
- Maulik Sudani
- 10 minutes ago
- 5 min read
Last Updated: May 21, 2026
TL;DR: Phenobarbital Injection — phenobarbital sodium formulated as a sterile parenteral solution — is the long-acting barbiturate anticonvulsant on the WHO Model List of Essential Medicines, used to control status epilepticus, neonatal and refractory seizures and for pre-operative sedation. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Phenobarbital Injection at our Gujarat, India facility under controlled-substance handling discipline, and supplies it to hospital tenders, distributors and brand owners in 30+ countries.
Key Takeaways
Drug class: Long-acting barbiturate anticonvulsant and sedative-hypnotic; a WHO Essential Medicine used for status epilepticus, neonatal seizures, refractory epilepsy and sedation — and a controlled substance requiring licensed, secured manufacturing.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, qualified ampoule and vial filling lines, terminal-sterilisation capability and dedicated controlled-drug handling with full chain-of-custody records.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, drug master files and CEP-style documentation for registrations across regulated and emerging markets.
End-to-end CMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tender-ready packaging and import-permit coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Phenobarbital Injection Demands a Premium Manufacturer
Phenobarbital Injection is one of the oldest anticonvulsants still in daily clinical use, and it remains indispensable. It is on the WHO Model List of Essential Medicines because it controls status epilepticus, neonatal seizures and refractory epilepsy reliably and affordably where newer agents are unavailable or unaffordable. In emergency neurology and neonatal intensive care, a dependable parenteral phenobarbital supply is not a convenience — it is the difference between a seizure stopped and a seizure that continues.
That clinical importance places two distinct pressures on the manufacturer. The first is pharmaceutical: phenobarbital sodium has limited aqueous stability and is typically formulated in a co-solvent vehicle of propylene glycol, ethanol and water for injection, with a high solution pH that demands tight control of fill, closure and glass compatibility. The second is regulatory: phenobarbital is a barbiturate and a controlled substance in most jurisdictions, so it can only be made in a licensed, physically secured facility with documented chain of custody from API receipt to finished-goods dispatch. Choosing a Phenobarbital Injection manufacturer that runs both sterile co-solvent formulation and controlled-substance governance as established disciplines is what keeps this essential medicine reliably available.
What Sets a World-Class Phenobarbital Injection Manufacturer Apart
A world-class manufacturer of Phenobarbital Injection invests in three areas competitors often underinvest in: controlled-substance compliance, robust co-solvent formulation, and a stability programme that mirrors real-world distribution. Controlled-substance compliance is more than a licence on the wall — it is secured storage with restricted access, reconciled API and finished-goods accounting, witnessed weighing and destruction of waste, audited chain-of-custody records, and the import and export permit support buyers need to move a scheduled drug legally across borders.
Robust formulation matters because phenobarbital sodium is not a simple aqueous fill. The propylene glycol and ethanol co-solvent system, the alkaline pH and the choice between terminal sterilisation and aseptic filling all have to be validated against the molecule's stability profile. World-class plants qualify their glass ampoules and closures for compatibility with the co-solvent vehicle, validate the sterilisation cycle, and document every parameter cleanly for audit — supported by electronic batch records that lock deviations the moment they occur.
Quality Systems Behind Every Phenobarbital Injection
Every Farbe Firma Phenobarbital Injection batch is released only after a full stack of quality checks: identity and assay by validated stability-indicating HPLC against USP, BP, IP or EP reference standards, pH, solution clarity and colour, fill-volume verification, particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration in dedicated isolators, and related-substances profiling against the appropriate monograph. Certificates of analysis are issued with full traceability back to API lot, excipient lot, primary-packaging lot and the qualified person responsible for release — and, for this controlled drug, tied to a reconciled quantity record.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous monitoring, calibrated sterilisation and depyrogenation equipment, validated filling and sealing recipes, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Stability is tracked under both long-term (25 °C / 60 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions — Zone IVb included — so we can assure customers the Phenobarbital Injection they buy today will meet specification when it reaches the patient months later in any climate.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Phenobarbital Injection Manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across antibiotics, analgesics, anaesthetics, anti-emetics and critical-care categories. For Phenobarbital Injection specifically, we supply standard ampoule presentations of phenobarbital sodium, with custom strengths, fill volumes and pack configurations available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier ready to hand for registration in the buyer's target market.
Our CDMO services scale cleanly from hospital pharmacy supply to full national tender procurement. We prepare full eCTD and ACTD modules, drug master files, ICH Q1A stability packages, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and — critically for a controlled substance — coordinate the import and export permit paperwork buyers need to clear customs legally. When a buyer needs Phenobarbital Injection on a tight deadline, our regulatory, manufacturing and logistics teams move as one — dossier, artwork, permits, production slot and shipment plan delivered as a single coordinated package, with a single accountable point of contact.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor; our quality unit responds to technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through formulation, co-solvent vehicle, sterilisation, container-closure and stability choices in real detail. For an emergency anticonvulsant where dosing accuracy, sterility and uninterrupted supply decide patient outcomes, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Phenobarbital Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Phenobarbital Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, qualified filling lines, qualified water-for-injection systems and validated environmental monitoring. WHO-GMP, USP, BP, IP and EP compliance documentation is available on request.
Which strengths and pack sizes of Phenobarbital Injection do you supply?
We supply phenobarbital sodium in standard ampoule presentations for intravenous and intramuscular use. Custom strengths, fill volumes, ampoule or vial closures and multi-pack configurations are available under contract manufacturing agreements — share your specification and our technical team will quote within 48 hours.
Can Farbe Firma handle phenobarbital as a controlled substance for export?
Yes. Phenobarbital is manufactured in our licensed, physically secured controlled-drug area with reconciled chain-of-custody records. Our regulatory team supports the import and export permit documentation required to ship a scheduled substance legally, and has done so for buyers across 30+ countries.
Can Farbe Firma support country-specific registrations for Phenobarbital Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability packages (long-term and accelerated), and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. Our regulatory team has supported registrations across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
What is the minimum order quantity for Phenobarbital Injection contract manufacturing?
MOQs vary by strength, label complexity, dossier requirements and the controlled-substance permits involved. For standard ampoule presentations we accommodate hospital-scale and full-tender-scale orders. Contact director@farbefirma.org for a specific quotation against your specification.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments